參考文獻 |
Bach, E. A., M. Aguet, and R. D. Schreiber 1997. The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15:563-591.
Berggren, K., E. Chernokalskaya, T. H. Steinberg, C. Kemper, M. F. Lopez, Z. Diwu, R. P. Haugland, and W. F. Patton 2000. Background-free, high sensitivity staining of proteins in one- and two-dimensional sodium dodecyl sulfate-polyacrylamide gels using a luminescent ruthenium complex. Electrophoresis 21:2509-2521.
Berman, H. M., J. Westbrook, Z. Feng, G. Gilliland, T. N. Bhat, H. Weissig, I. N. Shindyalov, and P. E. Bourne 2000. The Protein Data Bank. Nucleic Acids Res. 28:235-242.
Billiau, A. 1996. Interferon-gamma: biology and role in pathogenesis. Adv. Immunol. 62:61-130.
Blum, H., H. Beier, and H. J. Gross 1987. Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 8: 93-99.
Borden, E., and B. Williams 2000. Interferons, In R. Bast, D. Kufe, R. Pollock, R. Weichselbaum, J. Holland, and E. Frei (ed.), Cancer Medicine 5th ed. Hamilton, Canada.
Cantell, K., and J. Pirhonen 1996. IFN-gamma enhances production of IFN-alpha in human macrophages but not in monocytes. J. Interferon Cytokine Res. 16:461-463.
Castelruiz, Y., E. Larrea, P. Boya, M. P. Civeira, and J. Prieto 1999. Interferon alfa subtypes and levels of type I interferons in the liver and peripheral mononuclear cells in patients with chronic hepatitis C and controls. Hepatology 29:1900-1904.
Cinatl, J., B. Morgenstern, G. Bauer, P. Chandra, H. Rabenau, and H. W. Doerr 2003. Treatment of SARS with human interferons. Lancet. 362:293-294.
Darnell, J. E. Jr., I. M. Kerr, and G. R. Stark 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421.
DeMaeyer, E., and J. DeMaeyer-Guignard 1988. Interferons and Other Regulatory Cytokines. John Wiley, New York.
Dipaola, M., T. Smith, K. Ferencz-Biro, M. J. Liao, and D. Testa 1994. Interferon-alpha 2 produced by normal human leukocytes is predominantly interferon-alpha 2b. J. Interferon Res. 14:325-332.
Enserink, M. 2004. SARS treatment. Interferon shows promise in monkeys. Science 303:1273-1275.
Fish, E. N. 1992. Definition of receptor binding domains in interferon-alpha. J. Interferon Res. 12:257-266.
Fish, E. N., K. Banerjee, and N. Stebbing 1983. Human leukocyte interferon subtypes have different antiproliferative and antiviral activities on human cells. Biochem. Biophys. Res. Commun. 112:537-546.
Foster, G. R., O. Rodrigues, F. Ghouze, E. Schulte-Frohlinde, D. Testa, M. J. Liao, G. R. Stark, L. Leadbeater, and H. C. Thomas 1996. Different relative activities of human cell-derived interferon-alpha subtypes: IFN-alpha 8 has very high antiviral potency. J. Interferon Cytokine Res. 16:1027-1033.
Gevaert, K., and J. Vandekerckhove 2000. Protein identification methods in proteomics. Electrophoresis 21:1145-1154.
Goren, T., D. G. Fischer, and M. Rubinstein 1986. Human monocytes and lymphocytes produce different mixtures of alpha-interferon subtypes. J. Interferon Res. 6:323-329.
Haagmans, B. L., T. Kuiken, B. E. Martina, R. A. Fouchier, G. F. Rimmelzwaan, G. van Amerongen, D. van Riel, T. de Jong, S. Itamura, K. H. Chan, M. Tashiro, and A. D. Osterhaus 2004. Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat. Med. 10:290-293.
Hensley, L. E., L. E. Fritz, P. B. Jahrling, C. L. Karp, J. W. Huggins, and T. W. Geisbert 2004. Interferon-beta 1a and SARS coronavirus replication. Emerg. Infect. Dis. 10:317-319.
Herring, S. W., and R. K. Enns 1983. Rapid purification of leukocyte interferons by high-performance liquid chromatography. J. Chromatogr. 266:249-256.
Hilkens, C. M., J. F. Schlaak, and I. M. Kerr 2003. Differential responses to IFN-alpha subtypes in human T cells and dendritic cells. J Immunol. 171:5255-5263.
Huang, S. L., K. T. Pan, H. Y. Liu, and Y. C. Kuo 2004. Purification, identification and characterization of human interferon-? subtypes from human lymphoblastoid cell line. 3rd International Proteomics Conference. Taipei, Taiwan.
Ikai, A. 1980. Thermostability and aliphatic index of globular proteins.
J. Biochem. 88:1895-1898.
Isaacs, A., and J. Lindenmann 1957. Virus interference. I. The interferon. Proc. R. Soc. Ser. B. 147:258-267.
Juang, Y., W. Lowther, M. Kellum, W. C. Au, R. Lin, J. Hiscott, and P. M. Pitha 1998. Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. Proc. Natl. Acad. Sci. USA 95:9837-9842.
Klaus, W., B. Gsell, A. M. Labhardt, B. Wipf, and H. Senn 1997. The three-dimensional high resolution structure of human interferon alpha-2a determined by heteronuclear NMR spectroscopy in solution. J Mol Biol. 274:661-675.
Knight, E., and D. Fahey 1981. Human fibroblast interferon. An improved purification. J. Biol. Chem. 256:3609-3611.
Kontsek, P. 1994. Human type I interferons: structure and function. Acta. Virologica. 38:345-360.
Kontsek, P., and E. Kontseková 1997. Forty years of interferon. Acta. Virologica. 41:349-353.
Kontsek, P., G. Karayianni-Vascomcelos, and E. Kontseková 2003. The human interferon systems: Characterization and classification after discover of novel members. Acta. Virologica. 47:201-215.
Korn, A. P., D. R. Rose, and E. N. Fish 1994. Three-dimensional model of a human interferon-? consensus sequence. J. Interferon Res. 14:1-9.
Kotenko, S. V., G. Gallagher, V. V. Baurin, A. Lewis-Antes, M. Shen, N. K. Shah, J. A. Langer, F. Sheikh, H. Dickensheets, R. P. Donnelly 2003. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4:69-77.
Kyte, J., and R. F. Doolittle 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:105-132.
LaFleur, D. W., B. Nardelli, T. Tsareva, D. Mather, P. Feng, M. Semenuk, K. Taylor, M. Buergin, D. Chinchilla, V. Roshke, G. Chen, S. M. Ruben, P. M. Pitha, T. A. Coleman, and P. A. Moore 2001. Interferon-kappa, a novel type I interferon expressed in human keratinocytes. J. Biol. Chem. 276:39765-39771.
Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227:680-685.
Lefévre, F., and V. Boulay 1993. A novel and atypical type one interferon gene expressed by trophoblast during early pregnancy. J. Biol. Chem. 268:19760-19768.
Loutfy, M. R., L. M. Blatt, K. A. Siminovitch, S. Ward, B. Wolff, H. Lho, D. H. Pham, H. Deif, E. A. LaMere, M. Chang, K. C. Kain, G. A. Farcas, P. Ferguson, M. Latchford, G. Levy, J. W. Dennis, E. K. Lai, and E. N. Fish 2003. Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. JAMA. 290:3222-3228.
Marie, I., J. E. Durbin, and D. E. Levy 1998. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J. 17:6660-6669.
Martal, J., M. C. Lacroix, C. Loudes, M. Saunier, and S. Wintenberger-Torres 1979. Trophoblastin, an antiluteolytic protein present in early pregnancy in sheep. J. Reprod. Fertil. 56:63-73.
Mortz, E., T. N. Krogh, H. Vorum, and A. Gorg 2001. Improved silver staining protocols for high sensitivity protein identification using matrix-assisted laser desorption/ionization-time of flight analysis. Proteomics 1:1359-1363.
Nagano, Y., and Y. Kojima 1954. Pouvoir immunisant du virus vaccinal inactive par des rayons ultraviolets. C. R. Soc. Biol. 48:1700-1702.
Nyman, T. A., H. Tölö, J. Parkkinen, and N. Kalkkinen.1998. Identification of nine interferon-α subtypes produced by Sendai virusinduced human peripheral blood leucocytes. Biochem. J. 329:295-302. (a)
Nyman, T. A., N. Kalkkinen, H. Tölö, and J. Helln. 1998. Structural characterisation of N-linked and O-linked oligosaccharides derived from interferon-?2b and interferon-?14c produced by Sendai-virus-induced human peripheral blood leukocytes. Eur. J. Biochem. 253:485-493. (b)
O'Connell, K. L., and J. T. Stults 1997. Identification of mouse liver proteins on two-dimensional electrophoresis gels by matrix-assisted laser desorption/ionization mass spectrometry of in situ enzymatic digests. Electrophoresis 18:349-359.
Ortaldo, J. R., R. B. Herberman, C. Harvey, P. Osheroff, Y. C. Pan, B. Kelder, and S. Pestka 1984. A species of human alpha interferon that lacks the ability to boost human natural killer activity. Proc. Natl. Acad. Sci. USA 81:4926-4929.
Park, Z. Y. and D. H. Russell 2000. Thermal denaturation: a useful technique in peptide mass mapping. Anal. Chem. 72:2667-2670.
Park, Z. Y. and D. H. Russell 2001. Identification of individual proteins in complex protein mixtures by high-resolution, high-mass-accuracy MALDI TOF-mass spectrometry analysis of in-solution thermal denaturation/enzymatic digestion. Anal. Chem. 73:2558-2564.
Pestka, S., J. A. Langer, K. C. Zoon, and C. E. Samuel 1987. Interferons and their actions. Annu. Rev. Biochem. 56: 727-777.
Radhakrishnan, R., L. J. Walter, A. Hruza, P. Reichert, P. P. Trotta, T. L. Nagabhushan, and M. R. Walter 1996. Zinc mediated dimer of human interferon-alpha 2b revealed by X-ray crystallography. Structure 4:1543-1563.
Runkel, L., W. Meier, R. B. Pepinsky, M. Karpusas, A. Whitty, K. Kimball, M. Brickelmaier, C. Muldowney, W. Jones, and S. E. Goelz 1998. Structural and functional differences between glycosylated and non-glycosylated forms of human interferon-beta (IFN-beta). Pharm. Res. 15:641-649.
Samuel, C. E. 2001. Antiviral actions of interferons. Clinical Microbiology Reviews 14(4)778-809.
Sen, G. C. 2001. Viruses and interferons. Annu. Rev. Microbiol. 55:255-281.
Senda, T., S. Saitoh, and Y. Mitsui 1995. Refined crystal structure of recombinant murine interferon-beta at 2.15A˚ resolution. J. Mol. Biol. 253:187-207.
Sheppard, P., W. Kindsvogel, W. Xu, K. Henderson, S. Schlutsmeyer, T. E. Whitmore, R. Kuestner, U. Garrigues, C. Birks, J. Roraback, C. Ostrander, D. Dong, J. Shin, S. Presnell, B. Fox, B. Haldeman, E. Cooper, D. Taft, T. Gilbert, F. J. Grant, M. Tackett, W. Krivan, G. McKnight, C. Clegg, D. Foster, and K. M. Klucher 2003. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 4:63-68.
Shevchenko, A., M. Wilm, O. Vorm, and M. Mann 1996. Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal. Chem. 68:850-858.
Shirono, H., C. Ito, and J. Koga 1990. Studies on subtype composition in natural leukocyte interferon preparations. J. Virol. Methods. 27:1-10.
Soos, J. M., and B. E. Szente 2003. Type I interferons, pp. 549. In A. W. Thomson and M. T. Lotze (ed.), The Cytokine Handbook 4th ed. Elsevier Science Ltd., UK.
Stark, G. R., I. M. Kerr, B. Williams, R. Silverman, and R. Schreiber 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227-64.
Steinberg, T. H., K. Pretty On Top, K. N. Berggren, C. Kemper, L. Jones, Z. Diwu, R. P. Haugland, and W. F. Patton 2001. Rapid and simple single nanogram detection of glycoproteins in polyacrylamide gels and on electroblots. Proteomics 1:841-855.
Stroher, U., A. DiCaro, Y. Li, J. E. Strong, F. Aoki, F. Plummer, S. M. Jones, and H. Feldmann 2004. Severe acute respiratory syndrome-related coronavirus is inhibited by interferon- alpha. J. Infect. Dis. 189:1164-1167.
Sumner, L. W., B. Wolf-Sumner, S. P. White, and V. S. Asirvatham 2002. Silver stain removal using H2O2 for enhanced peptide mass mapping by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 16:160168.
Tan. Y. H., F. Barakat, W. Berthold, H. Smith-Johannsen, and C. Tan 1979. The isolation and amino acid/sugar composition of human fibroblastoid interferon. J. Biol. Chem. 254:8067-8073.
Tölö, H., H. L. Kauppinen, G. Alm, A. Perers, E. Lindeberg, V. Wahlstedt-Froberg, and J. Parkkinen 2001. Development of a highly purified multicomponent leukocyte IFN-alpha product. J. Interferon Cytokine Res. 21:913-920.
Utsumi, J., E. Matsuo-Ogawa, T. Nagahata, K. Kasama, Y. Kagawa, and Y. Satoh 1995. Carbohydrate-dependent biological activities of glycosylated human interferon-beta on human hepatoblastoma cells in vitro. Microbiol. Immunol. 39:81-86.
Utsumi, J., S. Yamazaki, K. Hosoi, H. Shimizu, K. Kawaguchi, and F. Inagaki 1986. Conformations of fibroblast and E. coli-derived recombinant human interferon-beta s as studied by nuclear magnetic resonance and circular dichroism. J. Biochem. 99:1533-1535.
Yan, J. X. , R. Wait, T. Berkelman, R. A. Harry, J. A. Westbrook, C. H. Wheeler, and M. J. Dunn 2000. A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry. Electrophoresis 21:3666-3672.
Yanai, Y., O. Sanou, T. Kayano, H. Ariyasu, K. Yamamoto, H. Yamauchi, H. Ikegami, and M. Kurimoto 2001. Analysis of the antiviral activities of natural IFN-alpha preparations and their subtype compositions. J. Interferon Cytokine Res. 21:835-841.
Yonehara, S., Y. Yanase, T. Sano, M. Imai, S. Nakasawa, and H. Mori 1981. Purification of human lymphoblastoid interferon by a simple procedure with high yields. J. Biol. Chem. 256:3770-3775.
Young, H. A. 1996. Regulation of interferon-gamma gene expression. J. Interferon Cytokine Res. 16:563-568.
Zavyalov, V. P., A. I. Denesyuk, and G. A. Zavyalov 1989. Theoretical analysis of conformation and active sites of interferons. Immunol. Lett. 22:173-182.
Zoon, K. C., D. Miller, J. Bekisz, D. zur Nedden, J. C. Enterline, N. Y. Nguyen, and R. Q. Hu 1992. Purification and characterization of multiple components of human lymphoblastoid interferon-alpha. J. Biol. Chem. 267:15210-15216.
Zoon, K. C., M. E. Smith, P. J. Bridgen, D. Nedden, and C. B. Anfinsen 1979. Purification and partial characterization of human lymphoblast interferon Proc. Natl. Acad. Sci. USA 76:5601-5605. |